Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Ann Afr Med ; 21(3): 301-304, 2022.
Article in English | MEDLINE | ID: covidwho-2055682

ABSTRACT

Irreversible visual loss due to retinal toxicity is one of the side effects of hydroxychloroquine (HCQ) therapy. The recent outbreak of the novel coronavirus-19 (COVID 19) has seen HCQ proposed as a possible treatment and prophylactic drug, leading to its increased use. Many are unaware of its ocular side effects. We describe a case of HCQ-induced retinopathy in a 46-year-old female who was referred by a rheumatologist for routine eye review.


Résumé La perte de vision irréversible secondaire à la toxicité rétinienne est l'un des effets indésirables du traitement à l'hydroxychloroquine (HCQ). Nous décrivons un cas d'une patiente âgée de 46 ans, présentant une rétinopathie secondaire au traitement à l'HCQ référée par un Rhumathologue pour un examen ophtalmique. Mots-clés: Hydroxychloroquine, rétine toxicité rétinienne, rétinopathie.


Subject(s)
Antirheumatic Agents , COVID-19 Drug Treatment , Retinal Diseases , Antirheumatic Agents/adverse effects , Female , Humans , Hydroxychloroquine/adverse effects , Kenya , Middle Aged , Retina , Retinal Diseases/chemically induced , Retinal Diseases/epidemiology , Tomography, Optical Coherence
SELECTION OF CITATIONS
SEARCH DETAIL